Readystate Asset Management LP Makes New Investment in Sabra Healthcare REIT, Inc. $SBRA

Readystate Asset Management LP purchased a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 71,748 shares of the real estate investment trust’s stock, valued at approximately $1,400,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Ameritas Advisory Services LLC acquired a new stake in shares of Sabra Healthcare REIT during the 2nd quarter worth approximately $82,000. HB Wealth Management LLC bought a new stake in Sabra Healthcare REIT during the 2nd quarter worth approximately $205,000. AlphaGrep UK Ltd bought a new stake in shares of Sabra Healthcare REIT during the second quarter worth $565,000. Concurrent Investment Advisors LLC increased its holdings in Sabra Healthcare REIT by 17.9% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 18,231 shares of the real estate investment trust’s stock worth $356,000 after purchasing an additional 2,770 shares in the last quarter. Finally, NEOS Investment Management LLC grew its holdings in shares of Sabra Healthcare REIT by 16.4% during the second quarter. NEOS Investment Management LLC now owns 51,819 shares of the real estate investment trust’s stock worth $1,011,000 after buying an additional 7,298 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Price Performance

Shares of SBRA opened at $20.78 on Tuesday. The stock’s 50-day moving average price is $20.63 and its two-hundred day moving average price is $20.19. Sabra Healthcare REIT, Inc. has a 12 month low of $17.17 and a 12 month high of $22.77. The company has a market capitalization of $5.31 billion, a PE ratio of 79.93, a PEG ratio of 1.58 and a beta of 0.65. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm had revenue of $230.11 million for the quarter, compared to analyst estimates of $219.39 million. During the same period in the prior year, the company posted $0.38 EPS. The business’s revenue for the quarter was up 24.7% compared to the same quarter last year. On average, analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is presently 461.54%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Wells Fargo & Company lifted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Scotiabank dropped their price target on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Cantor Fitzgerald raised their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Citizens Jmp lifted their target price on Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 22nd. Finally, Raymond James Financial upgraded Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $22.17.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.